Søgeresultater - Ruth Seggewiß-Bernhardt
- Showing 1 - 6 results of 6
-
1
Phase 1/1<scp>B</scp> trial of the heat shock protein 90 inhibitor <scp>NVP</scp>‐<scp>AUY</scp>922 as monotherapy or in combination with bortezomib in patients with relapsed or re... af Ruth Seggewiss‐Bernhardt, Ralf C. Bargou, Yeow Tee Goh, A. Keith Stewart, Andrew Spencer, Adrián Alegre, Joan Bladé, Oliver G. Ottmann, Cristina Fernandez‐Ibarra, Hong Lü, Scott Pain, Mikhail Akimov, Swaminathan P. Iyer
Udgivet 2015Artigo -
2
A multicenter phase 1 study of solitomab (MT110, AMG 110), a bispecific EpCAM/CD3 T-cell engager (BiTE®) antibody construct, in patients with refractory solid tumors af Maxim Kebenko, Marie-Elisabeth Goebeler, M. Wolf, Annette Hasenburg, Ruth Seggewiss‐Bernhardt, Barbara Ritter, Beate Rautenberg, Djordje Atanackovic, Andrea Kratzer, James B. Rottman, Matthias Friedrich, Eva Vieser, Stefanie Elm, Ingrid Patzak, Dorothea Wessiepe, Sabine Stienen, Walter Fiedler
Udgivet 2018Artigo -
3
Alpelisib Plus Fulvestrant in <i>PIK3CA</i>-Altered and <i>PIK3CA</i>-Wild-Type Estrogen Receptor–Positive Advanced Breast Cancer af Dejan Juric, Filip Janků, Jordi Rodón, Howard A. Burris, Ingrid A. Mayer, Martin Schüler, Ruth Seggewiß-Bernhardt, Marta Gil-Martín, Mark R. Middleton, José Baselga, Douglas Bootle, David Demanse, Lars Blumenstein, Karl Schumacher, Alan Huang, Cornelia Quadt, Hope S. Rugo
Udgivet 2018Artigo -
4
Phosphatidylinositol 3-Kinase α–Selective Inhibition With Alpelisib (BYL719) in <i>PIK3CA</i>-Altered Solid Tumors: Results From the First-in-Human Study af Dejan Juric, Jordi Rodón, Josep Tabernero, Filip Janků, Howard A. Burris, Jan H.M. Schellens, Mark R. Middleton, Jordan Berlin, Martin Schüler, Marta Gil-Martín, Hope S. Rugo, Ruth Seggewiß-Bernhardt, Alan Huang, Douglas Bootle, David Demanse, Lars Blumenstein, Christina Coughlin, Cornelia Quadt, José Baselga
Udgivet 2018Artigo -
5
Pasotuxizumab, a Bite <sup>®</sup> Immune Therapy for Castration-Resistant Prostate Cancer: Phase I, Dose-Escalation Study Findings af Horst-Dieter Hummel, Peter Kufer, Carsten Grüllich, Ruth Seggewiß-Bernhardt, Barbara Deschler-Baier, Manik Chatterjee, Maria-Elisabeth Goebeler, Kurt Miller, Maria De Santis, Wolfgang Loidl, Christian Dittrich, Andreas K. Buck, Constantin Lapa, Annette Thurner, Sabine Wittemer‐Rump, Gökben Koca, Oliver Boix, Wolf‐Dietrich Döcke, Ricarda Finnern, Helena Kusi, Antoinette Ajavon‐Hartmann, Sabine Stienen, Cyrus Sayehli, Bülent Polat, Ralf C. Bargou
Udgivet 2020Artigo -
6
Characteristics of immune checkpoint inhibitor-induced encephalitis and comparison with HSV-1 and anti-LGI1 encephalitis: A retrospective multicentre cohort study af Leonie Müller‐Jensen, Sarah Zierold, Judith M. Versluis, Wolfgang Boehmerle, Petra Huehnchen, Matthias Endres, Raphael Mohr, Annette Compter, Christian U. Blank, Tim Hagenacker, Friedegund Meier, Lydia Reinhardt, Anja Gesierich, Martin Salzmann, Jessica C. Hassel, Selma Ugurel, Lisa Zimmer, Patricia Banks, Lavinia Spain, J. Soon, Tomohiro Enokida, Makoto Tahara, Katharina C. Kähler, Ruth Seggewiss‐Bernhardt, Catriona Harvey, Georgina V. Long, Florian Schöberl, Louisa von Baumgarten, Thomas Hundsberger, Max Schlaak, Lars E. French, Samuel Knauß, Lucie Heinzerling
Udgivet 2022Artigo
Søgeredskaber:
Relaterede emner
Internal medicine
Medicine
Cancer
Gastroenterology
Oncology
Adverse effect
Phases of clinical research
Astrobiology
Breast cancer
Cancer research
Chemotherapy
Clinical trial
Immunology
Nausea
Physics
Refractory (planetary science)
Response Evaluation Criteria in Solid Tumors
Antibody
Autoimmune encephalitis
Bortezomib
CSF pleocytosis
Castration
Cerebrospinal fluid
Clinical endpoint
Cohort
Discontinuation
Encephalitis
Endometrial cancer
Epithelial cell adhesion molecule
Estrogen receptor